PL2651390T3 - Orodyspersyjna tabletka farmaceutyczna na bazie zolpidemu - Google Patents

Orodyspersyjna tabletka farmaceutyczna na bazie zolpidemu

Info

Publication number
PL2651390T3
PL2651390T3 PL11794519T PL11794519T PL2651390T3 PL 2651390 T3 PL2651390 T3 PL 2651390T3 PL 11794519 T PL11794519 T PL 11794519T PL 11794519 T PL11794519 T PL 11794519T PL 2651390 T3 PL2651390 T3 PL 2651390T3
Authority
PL
Poland
Prior art keywords
zolpidem
pharmaceutical tablet
orodispersible pharmaceutical
orodispersible
tablet
Prior art date
Application number
PL11794519T
Other languages
English (en)
Inventor
Annick Martinez
Olivier Rougeot
Yoshikatsu Yaguchi
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PL2651390T3 publication Critical patent/PL2651390T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11794519T 2010-12-16 2011-12-15 Orodyspersyjna tabletka farmaceutyczna na bazie zolpidemu PL2651390T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1060654A FR2968992B1 (fr) 2010-12-16 2010-12-16 Comprime pharmaceutique orodispersible a base de zolpidem
EP11794519.6A EP2651390B1 (en) 2010-12-16 2011-12-15 Zolpidem-based orodispersible pharmaceutical tablet
PCT/EP2011/072918 WO2012080399A1 (en) 2010-12-16 2011-12-15 Zolpidem-based orodispersible pharmaceutical tablet

Publications (1)

Publication Number Publication Date
PL2651390T3 true PL2651390T3 (pl) 2016-02-29

Family

ID=44269234

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11794519T PL2651390T3 (pl) 2010-12-16 2011-12-15 Orodyspersyjna tabletka farmaceutyczna na bazie zolpidemu

Country Status (9)

Country Link
US (1) US20130280327A1 (pl)
EP (1) EP2651390B1 (pl)
JP (1) JP5960158B2 (pl)
AR (1) AR084298A1 (pl)
ES (1) ES2545510T3 (pl)
FR (1) FR2968992B1 (pl)
PL (1) PL2651390T3 (pl)
TW (1) TWI537011B (pl)
WO (1) WO2012080399A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201808996SA (en) 2016-04-21 2018-11-29 Astrazeneca Ab Orally disintegrating tablets
CN116251069A (zh) * 2021-12-10 2023-06-13 山东新时代药业有限公司 一种酒石酸唑吡坦胃漂浮释放片及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
FR2787715B1 (fr) * 1998-12-23 2002-05-10 Synthelabo Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
ES2223730T3 (es) * 2001-06-29 2005-03-01 Quest International B.V. Un agente de enturbiamiento seco para mezclas bebibles secas y metodo para su fabricacion.
US20030165566A1 (en) * 2002-01-10 2003-09-04 O'toole Edel Sedative non-benzodiazepine formulations
FR2848855B1 (fr) 2002-12-23 2005-02-11 Aventis Pharma Sa Compositions pour administration orale de principes actifs necessitant un masquage du gout
KR20130116378A (ko) * 2004-02-17 2013-10-23 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
CA2556450C (en) * 2004-02-17 2013-08-06 Transoral Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20050244492A1 (en) * 2004-04-30 2005-11-03 Mehra Dev K Rapidly disintegrating tablets comprising titanium dioxide
AR056633A1 (es) * 2005-12-07 2007-10-17 Gador Sa Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones
JP2009114113A (ja) * 2007-11-06 2009-05-28 Nipro Corp 口腔内崩壊錠及びその製造方法
JP2011506279A (ja) * 2007-12-08 2011-03-03 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 経口で分散可能な錠剤
JP2009179604A (ja) * 2008-01-31 2009-08-13 Kyorin Pharmaceut Co Ltd 口腔内速崩壊性錠剤
NZ594207A (en) * 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
FR2949062B1 (fr) * 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments

Also Published As

Publication number Publication date
AR084298A1 (es) 2013-05-08
ES2545510T3 (es) 2015-09-11
US20130280327A1 (en) 2013-10-24
TWI537011B (zh) 2016-06-11
TW201231092A (en) 2012-08-01
EP2651390B1 (en) 2015-05-27
FR2968992A1 (fr) 2012-06-22
EP2651390A1 (en) 2013-10-23
FR2968992B1 (fr) 2013-02-08
JP5960158B2 (ja) 2016-08-02
WO2012080399A1 (en) 2012-06-21
JP2014501739A (ja) 2014-01-23

Similar Documents

Publication Publication Date Title
IL245328B (en) A pharmaceutical preparation containing carbatocin
EP2659874A4 (en) DEVICE FOR DISTRIBUTING PHARMACEUTICAL SOLUTIONS
EP2642983A4 (en) DEVICE INGREABLE WITH PHARMACEUTICAL PRODUCT
PL2619182T3 (pl) Kompozycja farmaceutyczna
ZA201200719B (en) Pharmaceutical formulation
IL225457A0 (en) Pharmaceutical composition
GB201008005D0 (en) Pharmaceutical compounds
GB2486567B (en) Pharmaceutical formulation
GB201010453D0 (en) Pharmaceutical composition
GB201017597D0 (en) Drug detection
GB201020161D0 (en) Pharmaceutical compounds
PL2538955T3 (pl) Formulacja farmaceutyczna lub nutraceutyczna
HRP20141173T1 (hr) Medikament koji sadrži miramistin
PL2394638T3 (pl) Nowe połączenia farmaceutyczne
GB201001911D0 (en) Pharmaceutical composition
ZA201201424B (en) Pharmaceutical dosage form
GB201012047D0 (en) Pharmaceutical formulations
GB201012046D0 (en) Pharmaceutical formulations
ZA201301851B (en) Pharmaceutical combinations
PL390620A1 (pl) Preparat farmaceutyczny
AU335048S (en) Tablet
GB201002451D0 (en) Pharmaceutical comopitions and devices
GB0910772D0 (en) Pharmaceutical
IL223324A (en) Pharmaceutical compounds
GB201018750D0 (en) Drug delivery system